Tech Company Financing Transactions
Endoron Medical Funding Round
Endoron Medical, operating out of Kfar Saba, secured $10 million from Sofinnova Partners and European Innovation Council Fund.
Transaction Overview
Company Name
Announced On
7/9/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Sofinnova Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the clinical validation of its flagship product, the catheter-based EndoStapling solution Aortoseal, as it progresses through its Investigational Device Exemption (IDE) approved Early Feasibility Study (EFS).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
21 Atir Yeda, St., 4th Floor
Kfar Saba, Undisclosed
Israel
Kfar Saba, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Overview
We strive to provide AAA patients undergoing Endovascular Aneurysm Repair with a long-lasting sealing and fixation solution for their endograft. Aortoseal was developed to mimic the reliable hand-sewn suturing technique from open surgery, evenly distributing staples around the circumference of the aorta, creating leak and migration free anastomosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jacques Seguin
Chief Executive Officer
Ronit Harpaz
Chief Marketing Officer
Ron Karmeli
Chief Technical Officer
Eyal Teichman
Browse more venture capital transactions:
Prev: 7/9/2024: Phyron venture capital transaction
Next: 7/9/2024: Gymdesk venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs